Home/Filings/4/0001104659-16-163869
4//SEC Filing

NOVELION THERAPEUTICS INC. 4

Accession 0001104659-16-163869

CIK 0000827809operating

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 4:03 PM ET

Size

6.1 KB

Accession

0001104659-16-163869

Insider Transaction Report

Form 4
Period: 2016-12-22
Buono Linda
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2016-12-22+97,40097,400 total
    Exercise: $8.65Exp: 2026-12-22Common Shares (97,400 underlying)
Footnotes (2)
  • [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
  • [F2]Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or one of its affiliates, 32,466 common shares underlying this stock option award will vest on December 22, 2017, 32,467 common shares underlying this stock option award will vest on December 22, 2018 and 32,467 common shares underlying this stock option award will vest on December 22, 2019.

Documents

1 file

Issuer

NOVELION THERAPEUTICS INC.

CIK 0000827809

Entity typeoperating
IncorporatedBritish Columbia, Canada

Related Parties

1
  • filerCIK 0000827809

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 4:03 PM ET
Size
6.1 KB